Table 2 Multimorbidity index conditions among participants in the UK Biobank Study
Multimorbidity index conditions | With severe SARS-CoV-2 infectiona N = 1706 (0.5%) | Without severe SARS-CoV-2 infectionb N = 358,577 (99.5%) | P value |
|---|---|---|---|
Hypertension | 676 (39.6) | 90,747 (25.3) | < 0.001 |
Asthma | 226 (13.3) | 41,382 (11.5) | 0.028 |
Diabetes | 170 (10.0) | 14,079 (3.9) | < 0.001 |
Cancer | 179 (10.5) | 27,108 (7.6) | < 0.001 |
Angina | 111 (6.5) | 10,037 (2.8) | < 0.001 |
Myocardial infarction | 102 (6.0) | 7096 (2.0) | < 0.001 |
Chronic kidney disease | 93 (5.5) | 7188 (2.0) | < 0.001 |
Stroke | 47 (2.8) | 3957 (1.1) | < 0.001 |
Atrial fibrillation | 26 (1.5) | 2508 (0.7) | < 0.001 |
Chronic obstructive pulmonary disease | 14 (0.8) | 929 (0.3) | < 0.001 |
Heart failure | 5 (0.3) | 146 (0.04) | < 0.001 |
Peripheral vascular disease | 4 (0.2) | 595 (0.2) | 0.488 |
Number of multimorbidity index conditions | |||
None | 683 (40.0) | 206,012 (57.5) | |
One | 592 (34.7) | 111,153 (31.0) | |
Two | 293 (17.2) | 32,059 (8.9) | |
Three | 96 (5.6) | 7341 (2.1) | |
Four | 27 (1.6) | 1646 (0.5) | |
Five | 12 (0.7) | 311 (0.1) | |
Six | 2 (0.1) | 47 (0.01) | |
Seven | 1 (0.1) | 7 (0.0) | |
Eight | 0 (0.0) | 1 (0.0) | < 0.001 |